Annual CFI
-$24.36 M
+$9.53 M+28.13%
31 December 2023
Summary:
Organogenesis Holdings annual cash flow from investing activities is currently -$24.36 million, with the most recent change of +$9.53 million (+28.13%) on 31 December 2023. During the last 3 years, it has fallen by -$866.00 thousand (-3.69%). ORGO annual CFI is now -1855.38% below its all-time high of -$1.25 million, reached on 31 December 2016.ORGO Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$2.57 M
-$689.00 K-36.65%
30 September 2024
Summary:
Organogenesis Holdings quarterly cash flow from investing activities is currently -$2.57 million, with the most recent change of -$689.00 thousand (-36.65%) on 30 September 2024. Over the past year, it has increased by +$3.41 million (+57.03%).ORGO Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$9.99 M
+$3.41 M+25.44%
30 September 2024
Summary:
Organogenesis Holdings TTM cash flow from investing activities is currently -$9.99 million, with the most recent change of +$3.41 million (+25.44%) on 30 September 2024. Over the past year, it has increased by +$21.70 million (+68.47%).ORGO TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ORGO Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +28.1% | +57.0% | +68.5% |
| 3 y3 years | -3.7% | +84.6% | +68.2% |
| 5 y5 years | -1212.7% | -101.5% | -218.5% |
ORGO Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -3.7% | +28.1% | -36.6% | +84.6% | at high | +72.3% |
| 5 y | 5 years | -1212.7% | +28.1% | -101.5% | +84.6% | -218.5% | +72.3% |
| alltime | all time | -1855.4% | +28.1% | <-9999.0% | +84.6% | <-9999.0% | +72.3% |
Organogenesis Holdings Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$2.57 M(+36.6%) | -$9.99 M(-25.4%) |
| June 2024 | - | -$1.88 M(-15.4%) | -$13.40 M(-29.5%) |
| Mar 2024 | - | -$2.22 M(-33.2%) | -$19.02 M(-21.9%) |
| Dec 2023 | -$24.36 M(-28.1%) | -$3.32 M(-44.4%) | -$24.36 M(-23.1%) |
| Sept 2023 | - | -$5.98 M(-20.3%) | -$31.70 M(-12.2%) |
| June 2023 | - | -$7.50 M(-0.8%) | -$36.12 M(+3.8%) |
| Mar 2023 | - | -$7.56 M(-29.0%) | -$34.79 M(+2.6%) |
| Dec 2022 | -$33.90 M(+8.6%) | -$10.66 M(+2.4%) | -$33.90 M(+19.1%) |
| Sept 2022 | - | -$10.40 M(+68.6%) | -$28.47 M(-18.1%) |
| June 2022 | - | -$6.17 M(-7.6%) | -$34.77 M(+5.6%) |
| Mar 2022 | - | -$6.67 M(+27.6%) | -$32.94 M(+5.5%) |
| Dec 2021 | -$31.22 M(+32.9%) | -$5.23 M(-68.7%) | -$31.22 M(-0.6%) |
| Sept 2021 | - | -$16.70 M(+285.5%) | -$31.41 M(+17.8%) |
| June 2021 | - | -$4.33 M(-12.6%) | -$26.67 M(+10.2%) |
| Mar 2021 | - | -$4.96 M(-8.5%) | -$24.21 M(+3.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | -$23.50 M(+276.9%) | -$5.42 M(-54.7%) | -$23.50 M(+9.1%) |
| Sept 2020 | - | -$11.96 M(+538.0%) | -$21.54 M(+98.5%) |
| June 2020 | - | -$1.88 M(-55.8%) | -$10.85 M(+6.8%) |
| Mar 2020 | - | -$4.24 M(+22.7%) | -$10.16 M(+63.0%) |
| Dec 2019 | -$6.23 M(+235.9%) | -$3.46 M(+171.2%) | -$6.23 M(+98.7%) |
| Sept 2019 | - | -$1.27 M(+7.7%) | -$3.14 M(+12.1%) |
| June 2019 | - | -$1.18 M(+273.5%) | -$2.80 M(+32.8%) |
| Mar 2019 | - | -$317.00 K(-12.4%) | -$2.11 M(+13.6%) |
| Dec 2018 | -$1.86 M(-87.5%) | -$362.00 K(-61.4%) | -$1.86 M(+24.2%) |
| Sept 2018 | - | -$937.00 K(+90.4%) | -$1.49 M(+168.2%) |
| June 2018 | - | -$492.00 K(+656.9%) | -$557.00 K(+756.9%) |
| Mar 2018 | - | -$65.00 K(-94.8%) | -$65.00 K(-94.8%) |
| Dec 2017 | -$14.87 M(+1093.7%) | - | - |
| Dec 2016 | -$1.25 M | -$1.25 M(<-9900.0%) | -$1.25 M(<-9900.0%) |
| June 2016 | - | $0.00 | $0.00 |
FAQ
- What is Organogenesis Holdings annual cash flow from investing activities?
- What is the all time high annual CFI for Organogenesis Holdings?
- What is Organogenesis Holdings annual CFI year-on-year change?
- What is Organogenesis Holdings quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Organogenesis Holdings?
- What is Organogenesis Holdings quarterly CFI year-on-year change?
- What is Organogenesis Holdings TTM cash flow from investing activities?
- What is the all time high TTM CFI for Organogenesis Holdings?
- What is Organogenesis Holdings TTM CFI year-on-year change?
What is Organogenesis Holdings annual cash flow from investing activities?
The current annual CFI of ORGO is -$24.36 M
What is the all time high annual CFI for Organogenesis Holdings?
Organogenesis Holdings all-time high annual cash flow from investing activities is -$1.25 M
What is Organogenesis Holdings annual CFI year-on-year change?
Over the past year, ORGO annual cash flow from investing activities has changed by +$9.53 M (+28.13%)
What is Organogenesis Holdings quarterly cash flow from investing activities?
The current quarterly CFI of ORGO is -$2.57 M
What is the all time high quarterly CFI for Organogenesis Holdings?
Organogenesis Holdings all-time high quarterly cash flow from investing activities is $0.00
What is Organogenesis Holdings quarterly CFI year-on-year change?
Over the past year, ORGO quarterly cash flow from investing activities has changed by +$3.41 M (+57.03%)
What is Organogenesis Holdings TTM cash flow from investing activities?
The current TTM CFI of ORGO is -$9.99 M
What is the all time high TTM CFI for Organogenesis Holdings?
Organogenesis Holdings all-time high TTM cash flow from investing activities is $0.00
What is Organogenesis Holdings TTM CFI year-on-year change?
Over the past year, ORGO TTM cash flow from investing activities has changed by +$21.70 M (+68.47%)